Maribel Salas

Summary

Affiliation: Caro Research Institute
Country: USA

Publications

  1. ncbi Are proton pump inhibitors the first choice for acute treatment of gastric ulcers? A meta analysis of randomized clinical trials
    Maribel Salas
    Caro Research Institute, 336 Baker Avenue, Concord, MA 01742, USA
    BMC Gastroenterol 2:17. 2002
  2. ncbi Are hypoglycaemia and other adverse effects similar among sulphonylureas?
    Maribel Salas
    Caro Research Institute, Boston, Massachusetts, USA
    Adverse Drug React Toxicol Rev 21:205-17. 2002
  3. ncbi Modeling the efficiency of reaching a target intermediate end point: a case study in type 2 diabetes in the United States
    J Jaime Caro
    Caro Research Institute, Concord, MA, USA
    Value Health 7:13-21. 2004
  4. ncbi Cost-effectiveness of oral hypoglycaemic agents for the treatment of type 2 diabetes mellitus
    Alexandra Ward
    Caro Research Institute, 336 Baker Avenue, Concord, MA 01742, USA
    Expert Opin Pharmacother 6:601-8. 2005
  5. ncbi Assessing the health and economic impact of galantamine treatment in patients with Alzheimer's disease in the health care systems of different countries
    Jaime Caro
    Caro Research Institute, Concord, Massachusetts, USA
    Drugs Aging 21:677-86. 2004
  6. ncbi Economic analysis of galantamine, a cholinesterase inhibitor, in the treatment of patients with mild to moderate Alzheimer's disease in the Netherlands
    J Jaime Caro
    Caro Research Institute, Boston, Mass, USA
    Dement Geriatr Cogn Disord 14:84-9. 2002
  7. ncbi Health and economic effects of adding nateglinide to metformin to achieve dual control of glycosylated hemoglobin and postprandial glucose levels in a model of type 2 diabetes mellitus
    Maribel Salas
    Caro Research Institute, Boston, Massachusetts, USA
    Clin Ther 24:1690-705. 2002
  8. ncbi Quality of clinical documentation and anticoagulation control in patients with chronic nonvalvular atrial fibrillation in routine medical care
    Jack Ansell
    Department of Medicine, Boston University, Boston, MA 02118, USA
    Am J Med Qual 22:327-33. 2007

Collaborators

Detail Information

Publications8

  1. ncbi Are proton pump inhibitors the first choice for acute treatment of gastric ulcers? A meta analysis of randomized clinical trials
    Maribel Salas
    Caro Research Institute, 336 Baker Avenue, Concord, MA 01742, USA
    BMC Gastroenterol 2:17. 2002
    ....
  2. ncbi Are hypoglycaemia and other adverse effects similar among sulphonylureas?
    Maribel Salas
    Caro Research Institute, Boston, Massachusetts, USA
    Adverse Drug React Toxicol Rev 21:205-17. 2002
    ..More work in this area is needed to homogenise the definition of hypoglycaemia, to get consensus on the methods for detection and data collection, as well as to further patient and physician education...
  3. ncbi Modeling the efficiency of reaching a target intermediate end point: a case study in type 2 diabetes in the United States
    J Jaime Caro
    Caro Research Institute, Concord, MA, USA
    Value Health 7:13-21. 2004
    ..A case study addresses the economic efficiency of obtaining dual glycemic control over time, according to initial choice of treatment...
  4. ncbi Cost-effectiveness of oral hypoglycaemic agents for the treatment of type 2 diabetes mellitus
    Alexandra Ward
    Caro Research Institute, 336 Baker Avenue, Concord, MA 01742, USA
    Expert Opin Pharmacother 6:601-8. 2005
    ..However, additional treatment costs of achieving recommended glycaemic control levels are predicted to be at least partially offset in the long term by the reduction of diabetes-related complications and their related management costs...
  5. ncbi Assessing the health and economic impact of galantamine treatment in patients with Alzheimer's disease in the health care systems of different countries
    Jaime Caro
    Caro Research Institute, Concord, Massachusetts, USA
    Drugs Aging 21:677-86. 2004
    ..CONCLUSION: In addition to the clinical benefits associated with galantamine treatment, the savings predicted from delaying FTC may offset the treatment costs...
  6. ncbi Economic analysis of galantamine, a cholinesterase inhibitor, in the treatment of patients with mild to moderate Alzheimer's disease in the Netherlands
    J Jaime Caro
    Caro Research Institute, Boston, Mass, USA
    Dement Geriatr Cogn Disord 14:84-9. 2002
    ..The economic impact of dementia on the Dutch health and social services is substantial...
  7. ncbi Health and economic effects of adding nateglinide to metformin to achieve dual control of glycosylated hemoglobin and postprandial glucose levels in a model of type 2 diabetes mellitus
    Maribel Salas
    Caro Research Institute, Boston, Massachusetts, USA
    Clin Ther 24:1690-705. 2002
    ..The major factor in cost savings was fewer complications due to nephropathy. The increased drug treatment costs were expected to be offset by the long-term savings from reducing complication rates...
  8. ncbi Quality of clinical documentation and anticoagulation control in patients with chronic nonvalvular atrial fibrillation in routine medical care
    Jack Ansell
    Department of Medicine, Boston University, Boston, MA 02118, USA
    Am J Med Qual 22:327-33. 2007
    ..Anticoagulation quality and record documentation were retrospectively assessed in patients with chronic nonvalvular atrial fibrillation (CNVAF) managed in a routine care setting...